| Cardiovascular Risk Management |
1 |
1 |
| Obesity |
0 |
1 |
| Coronary Artery Disease (CAD) |
0 |
0.74 |
| Bariatric Surgery |
0 |
0.69 |
| Hypertension |
0 |
0.59 |
| Heart Failure (HF) |
0 |
0.55 |
| Adverse Effects |
0 |
0.53 |
| Cardiovascular disease |
0 |
0.53 |
| Weight Loss |
0 |
0.53 |
| Weight Management |
0 |
0.41 |
| Patient Safety |
0 |
0.39 |
| Heart |
0 |
0.35 |
| Body Mass Index |
0 |
0.23 |
| Hemoglobin A1c |
0 |
0.17 |
| Lipids Management |
0 |
0.16 |
| Renal Disease |
0 |
0.16 |
| Blood |
0 |
0.12 |
| Hemoglobin |
0 |
0.12 |
| LDL Cholesterol |
0 |
0.12 |
| Cerebrovascular Accident |
0 |
0.11 |
| Myocardial Infarction (MI) |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.07 |
| Animal Research |
0 |
0.06 |
| Artery |
0 |
0.06 |
| Biomarker |
0 |
0.06 |
| Endocrinology |
0 |
0.06 |
| Epidemic |
0 |
0.06 |
| Health Care Cost |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Infarction |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Kidney |
0 |
0.06 |
| Nausea |
0 |
0.06 |
| New York |
0 |
0.06 |
| Pandemic |
0 |
0.06 |
| Patient History |
0 |
0.06 |
| Platelet Count |
0 |
0.06 |
| Prediabetes |
0 |
0.06 |
| Statins |
0 |
0.06 |
| Statistics |
0 |
0.06 |
| Surgery |
0 |
0.06 |
| Texas |
0 |
0.06 |
| Tissue |
0 |
0.06 |